Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
90 hedge funds and large institutions have $813M invested in Enfusion, Inc. in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 7 closing their positions.
229% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 7
36% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 22
22% more funds holding
Funds holding: 74 → 90 (+16)
12% more capital invested
Capital invested by funds: $724M → $813M (+$89.8M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$26.1M |
| 2 |
1WCM
12 West Capital Management
New York
|
+$11.6M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
+$5.88M |
| 4 |
JP Morgan Chase
New York
|
+$3.68M |
| 5 |
Two Sigma Investments
New York
|
+$3.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dragoneer Investment Group
San Francisco,
California
|
-$19.9M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$11.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.7M |
| 4 |
FC
Franchise Capital
Grand Cayman,
Cayman Islands
|
-$1.38M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$924K |
ENFN Hedge Fund Activity: Q1 2023 in Review
90 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2023, worth a combined $813M — up 12% from $724M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ENFN positions and 7 closed out — a net gain of 16 holders — while 30 added to existing stakes and 22 trimmed.
The largest buyer was Brown Capital Management, adding an estimated $26.1M. The largest seller was Dragoneer Investment Group, cutting an estimated $19.9M.
- 90 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2023, up from 74 in Q4 2022.
- Funds reported $813M of Enfusion, Inc. stock for Q1 2023, up 12% quarter-over-quarter.
- 23 funds opened new Enfusion, Inc. positions in Q1 2023 and 7 closed out, a net change of +16 holders.
- The largest Enfusion, Inc. buyer in Q1 2023 was Brown Capital Management, an estimated $26.1M added.
- The largest Enfusion, Inc. seller in Q1 2023 was Dragoneer Investment Group, an estimated $19.9M sold.
Based on aggregated 13F filings for Q1 2023.